A Model of the Oscillatory Metabolism of Activated Neutrophils  by Olsen, Lars F. et al.
Biophysical Journal Volume 84 January 2003 69–81 69
A Model of the Oscillatory Metabolism of Activated Neutrophils
Lars F. Olsen,*y Ursula Kummer,* Andrei L. Kindzelskii,z and Howard R. Pettyz
*European Media Laboratory, Schloss-Wolfsbrunnenweg 33, D-69118 Heidelberg, Germany; yDepartment of Biochemistry and Molecular
Biology, Syddansk Universitet, DK-5230 Odense M, Denmark; and zDepartment of Biological Sciences, Wayne State University, Detroit,
Michigan 48202 USA
ABSTRACT We present a two-compartment model to explain the oscillatory behavior observed experimentally in activated
neutrophils. Our model is based mainly on the peroxidase-oxidase reaction catalyzed by myeloperoxidase with melatonin as a
cofactor and NADPH oxidase, a major protein in the phagosome membrane of the leukocyte. The model predicts that after
activation of a neutrophil, an increase in the activity of the hexose monophosphate shunt and the delivery of myeloperoxidase
into the phagosome results in oscillations in oxygen and NAD(P)H concentration. The period of oscillation changes from >200 s
to 10–30 s. The model is consistent with previously reported oscillations in cell metabolism and oxidant production. Key features
and predictions of the model were conﬁrmed experimentally. The requirement of the hexose monophosphate pathway for 10 s
oscillations was veriﬁed using 6-aminonicotinamide and dexamethasone, which are inhibitors of glucose-6-phosphate
dehydrogenase. The role of the NADPH oxidase in promoting oscillations was conﬁrmed by dose-response studies of the effect
of diphenylene iodonium, an inhibitor of the NADPH oxidase. Moreover, the model predicted an increase in the amplitude of
NADPH oscillations in the presence of melatonin, which was conﬁrmed experimentally. Successful computer modeling of
complex chemical dynamics within cells and their chemical perturbation will enhance our ability to identify new antiinﬂammatory
compounds.
INTRODUCTION
Neutrophilic leukocytes constitute our primary defense
against invading pathogens. Upon bacterial invasion,
neutrophils leave the bloodstream through transiently
generated gaps between the endothelial cells and migrate
actively toward the site of infection. Here they engulf and kill
the bacteria. The process of phagocytosis continues until the
bacterium is completely internalized, surrounded by mem-
brane in the phagosome. The bacterium in the phagosome is
destroyed by an arsenal of cytotoxic agents. Many of these
digestive and antibacterial compounds originate from
cytoplasmic granules that are emptied into the phagosome
upon activation. Then follows a large burst in nonmitochon-
drial respiratory activity, much of which can be ascribed
to the NADPH oxidase complex that assembles at the
phagosomal membrane (Henderson and Chappell, 1996).
Electrons are transferred from cytoplasmic NADPH to
oxygen on the phagosomal side of the membrane, generating
the so-called reactive oxygen species, e.g., superoxide,
hydrogen peroxide, hydroxyl radical, and singlet oxygen.
The NADPH used is itself produced by the hexose
monophosphate shunt. Although there is good evidence that
the respiratory burst is associated with NADPH oxidase
activity, other proteins also participate in the oxidative
destruction of targets. One protein is myeloperoxidase,
which is, in fact, the most abundant protein of the neutrophil
(Klebanoff, 1991). Myeloperoxidase, which is stored in
the azurophil granules from which it is released into the
phagosome upon activation, is believed to catalyze the
reaction of hydrogen peroxide with Cl ions to form HOCl,
which also has antibacterial activity (Dunford, 1999;
Hampton et al., 1998; Klebanoff, 1991).
Recently, it was shown that in migrating neutrophils the
concentrations of NAD(P)H and reactive oxygen species
oscillate (Petty, 2001; Amit et al., 1999). The mechanism
responsible for such oscillations is not known. However,
various known biochemical oscillators such as glycolysis
and cytosolic calcium (Petty, 2001) have been proposed as
sources of the oscillations. It is quite likely that several
biochemical oscillators operate together to produce the
experimentally observed oscillations. Here wewish to present
evidence for another such oscillator that involves myeloper-
oxidase, melatonin, NADPH, and NADPH oxidase.
In a previous paper (Olsen et al., 2001) it was shown that
melatonin activates the reaction:
2NADH1O2 ! 2NAD112H2O
catalyzed by horseradish peroxidase, lactoperoxidase, or soy
bean peroxidase. This reaction is also known as the per-
oxidase-oxidase (PO) reaction (Scheeline et al., 1997). In
addition to activating the PO reaction. melatonin also
induces oscillations in this reaction when the pH is between
4 and 6. Because lactoperoxidase and myeloperoxidase are
structurally very similar (Dunford, 1999) and because
melatonin has been shown to be a substrate for the classical
peroxidase reaction:
YH21H2O2 ! Y12H2O
catalyzed by both horseradish peroxidase and myeloper-
oxidase (Silva et al., 2000; Allegra et al., 2001, Ximenes et al.,
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2001), it is tempting to suggest that a myeloperoxidase-
catalyzed PO reaction could also be involved in the
oscillations in neutrophils. Myeloperoxidase has been shown
to catalyze the PO reaction (Fujimoto et al., 1993).
Furthermore, peroxidases do not discriminate between
NADH and NADPH as the reducing substrate (Nakamura
et al., 1969). Finally, it has been shown that leukocytes
may synthesize melatonin (Finocchiaro et al., 1991).
Here we ﬁrst study experimentally the PO reaction
catalyzed by horseradish peroxidase enclosed in liposomes
while the substrates NADH and O2 are continuously
supplied to the external medium. Melatonin is added to the
reaction mixture in order to mediate electron trafﬁcking
between NADH and peroxidase. We then use the experi-
mental results to develop a model of the PO reaction
catalyzed by myeloperoxidase in neutrophils. The computa-
tional results are tested by performing key experiments on
neutrophils conﬁrming the main results of the simulations.
MATERIALS AND METHODS
Materials
Reagents were obtained from Sigma-Aldrich (St. Louis, MO) unless
otherwise noted. Horseradish peroxidase (330 units/mg, RZ ¼ 3.0) and
NADH (grade II) were purchased from Boehringer Mannheim, (Mannheim,
Germany) whereas L-a-phosphatidylcholine (based on palmitoyl-oleoyl
phosphatidylcholine) (>99%) was purchased from Avanti Polar Lipids
(Alabaster, AL).
Liposomes
Liposomes were made of palmitoyl-oleoyl phosphatidylcholine. The lipid
was ﬁrst dissolved in chloroform and placed in a vacuum chamber overnight.
The resulting lipid ﬁlm was then hydrated by adding an aqueous solution
containing 20 mM horseradish peroxidase and 0.1 M sodium acetate buffer,
pH 5.1. The ﬁnal concentration of lipid in the suspension was 10 mM. The
lipid suspension was placed in a heating bath at 358C for at least 2 h. The
suspension was vigorously shaken from time to time. Unilamellar vesicles
containing horseradish peroxidase were made by extrusion (MacDonald et
al., 1991). The lipid suspension was passed through a Millipore HTTP
(Millipore, Glostrup, Denmark) ﬁlter with a pore size of 0.4 mM under an N2
pressure of 10 atmospheres 11 times. The liposomes were separated from the
peroxidase-containing solution by elution through a Sephacryl S-200 HR
(Amersham Biosciences, Hørsholm, Denmark) column using 0.1 M sodium
acetate, pH 5.1, as the eluent.
PO reaction
Experiments were conducted at 28 (60.1)8C in a 2.0 3 2.0 3 4.3 cm
quartz cuvette ﬁtted with a thermostating jacket. The cuvette was connected
to a Zeiss Specord S 10 diode array spectrophotometer (Carl Zeiss, Jena,
Germany) through optical ﬁbers. Oxygen in the solution was measured with
a Clark-type oxygen electrode (Microelectrodes, Bedford, NH). The reaction
mixture consisted of an 8 ml well-stirred homogeneous aqueous solution
containing 0.1 M sodium acetate, pH 5.1, 200 mM melatonin and
peroxidase-containing liposomes (see above). O2 is entering the reaction
mixture from a 1.05% (v/v) O2/N2 gas mixture above the liquid. The rate of
diffusion into the liquid follows Fick’s law and the oxygen transfer constant
was measured as 5.6 3 103 (60.1 3 103) s1 corresponding to a stirring
rate of 900 (610) rpm. NADH was supplied to the reaction mixture by
infusion of a 0.1 M stock solution through a capillary whose tip was below
the surface of the liquid. The infusion was mediated by a Harvard Apparatus
(Holliston, MA) model 22 infusion pump and the infusion rate was 35 ml/h.
Cells
Human peripheral blood neutrophils were prepared as previously described
(Amit et al., 1999). Cells were suspended in Hanks’ balanced salt solution
containing glucose but not phenol red. Morphologically polarized cells
with well-deﬁned uropods, which are characteristics of cell motility, were
examined.
Detection of NAD(P)H oscillations
Metabolic oscillations were detected using NAD(P)H microscopy (Amit et
al., 1999; Rosenspire et al. 2000). NAD(P)H autoﬂuorescence was detected
using narrow bandpass interference ﬁlters (AF series, Omega Optical,
Brattleboro, VT) and a dichroic mirror. An iris diaphragm was adjusted to
exclude light from neighboring cells. A cooled photomultiplier tube held in a
Products for Research (Danvers, MA) housing attached to a Zeiss micro-
scope was used (Rosenspire et al., 2000).
Imaging spectrophotometry
of chemiluminescence
Cells were observed microscopically at 378C. Imaging spectrophotometry
was performed using an Axiovert 135 ﬂuorescence microscope with a quartz
condenser and quartz objective (Carl Zeiss, New York). To increase light
collection efﬁciency, the microscope’s bottom port was employed. This port
was ﬁberoptically coupled to the input of an Acton 150 (Acton Instruments,
Acton, MA) imaging spectrophotometer (Petty et al., 2000). The exit side
was connected to a liquid N2-cooled intensiﬁer attached to a Peltier-cooled
IMAX-512 camera (208C) (Princeton Instruments, Trenton, NJ). The
camera was controlled by a high-speed Princeton ST-133 interface and a
Stanford Research Systems (Sunnyvale, CA) DG-535 delay gate generator
(Petty et al., 2000). A Dell Precision 410 workstation with an 800 MHz
processor, 1.0 Gb RAM, 10 Mb onboard cache, and a high-speed Lava Dual
PCI enhanced port (Rexdale, CA) was used. Winspec (Princeton) software
was employed.
RESULTS
Experiments with liposomes
We measured the oxygen consumption and the NADH
oxidation rates of peroxidase-containing liposomes either by
adding a ﬁxed amount of NADH (100–125 mM) or by
infusing 0.1 M NADH at a ﬁxed rate to the reaction mixture
containing liposomes. In the ﬁrst case an appreciable oxygen
consumption and NADH oxidation rate was only obtained if
melatonin (at a concentration of 200 mM) was also present. If
melatonin was replaced by 4-hydroxybenzoic acid, no
stimulation in NADH oxidation was observed. These
observations indicate that the peroxidase is shielded from
NADH in the solution, as both melatonin and 4-hydroxy-
benzoic acid are activators of the PO reaction (Olsen et al.,
2001; Kummer et al., 1997; Hauser and Olsen, 1998).
However, unlike melatonin, which is uncharged at pH 5.1,
4-hydroxybenzoic acid is a polar molecule with a net
negative charge under the present experimental conditions.
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The latter could prevent 4-hydroxybenzoic acid from
diffusing across the liposomal membrane and thus inducing
an acceleration in the PO reaction. Consequently, our results
suggest that peroxidase is shielded from NADH in the
solution by a hydrophobic barrier.
Next we investigated whether the peroxidase-containing
liposomes could catalyze an oscillating PO reaction in the
presence of melatonin. Fig. 1 shows a time series of the
recorded absorbance changes at 360 nm and 418 nm plus the
oxygen concentration when NADH is infused into a reaction
mixture containing liposomes and melatonin. The absorb-
ance changes at the two wavelengths are characteristic for
NADH and peroxidase compound III, respectively. We note
that the reaction oscillates, although the oscillations are
strongly damped. Using an extinction coefﬁcient for
compound III at 418 nm of 1.16 3 105 M1 cm1 (Olsen
et al., 2001), we can estimate a concentration of peroxidase
in the suspension of 84 nM. This corresponds to a con-
centration of peroxidase in the liposome of 20 mM as
expected if peroxidase is evenly distributed between the
external solution and the liposome aqueous fraction after the
preparation of the liposomes.
Thus, our experiments suggest that in the presence of
melatonin, horseradish peroxidase can catalyze an oscillating
PO reaction even though the enzyme and one of its substrates
(NADH) are located in different compartments separated by
a lipid membrane.
Construction of the model
In the construction of a model for a myeloperoxidase-
catalyzed PO reaction in neutrophils, one has to consider that
the enzyme and one of its substrates (NADPH) are not
located in the same compartment. Although NADPH is
formed in the cytoplasm, the enzyme is situated either in the
azurophil granules or in the phagosome. In the previous
section we showed that it is possible for peroxidase to
catalyze the PO reaction even when the substrate NADH and
the enzyme are separated by a lipid membrane, provided that
melatonin (or another nonpolar activator of peroxidase) is
also present. Thus, we break our model of the PO reaction in
neutrophils up into reactions that can occur in the cytosol and
those that occur in the phagosome. Most of the reactions are
well-documented and the in vitro rate constants are known
(see Scheeline et al., 1997, for a review). The reactions and
diffusion terms are all listed in Table 1 and the equation
numbers listed below all refer to the numbers in the table.
Reactions occurring in the cytoplasm
These include ﬁrst the (very) slow autooxidation of NADPH:
NADPH1O2 ! NADP11H2O2: (7)
The reaction is slow at pH around 7, but it may be
catalyzed by a number of organic substances, e.g., methylene
blue (Sevcik and Dunford, 1991). Here the reaction is
modeled as a second order reaction with a very low rate
constant (of the order of 1 M1 s1).
Another reaction likely to take place in the cytosol is the
reduction of molecular oxygen by the NADP radical:
NADP1O2 ! NADP11O2 : (8)
The radical NADP is in turn regenerated in the reaction:
MLT1NADPH ! MLTH1NADP; (10)
where MLTH and MLT indicate melatonin and its free
radical, respectively. The melatonin radical is formed in the
reactions of melatonin with peroxidase compound I and
compound II, respectively (see below).
Superoxide (O2) formed in reaction (8) either dispropor-
tionates:
2H112O2 ! O21H2O2 (9)
or it diffuses from the cytoplasm into the phagosome:
O2 ðcytoplasmÞO2 ðphagosomeÞ: (18)
As for the disproportionation of superoxide, we have
assumed second order kinetics, but we have also set the
second order rate constant more than 50 times as high as
it should be. This is done to account for the superoxide
dismutase activity in the cytoplasm. As for the diffusion of
superoxide from cytoplasm to phagosome the rate is prob-
ably extremely slow. We consider the rate of this process to
be essentially zero in our simulations.
FIGURE 1 Time series of the absorbance changes at 360 nm and 418 nm
plus the oxygen concentration in the peroxidase-oxidase reaction catalyzed
by peroxidase-containing liposomes. The reaction mixture contained
liposomes corresponding to 0.25 mM phosphatidylcholine. Other exper-
imental conditions as described in the experimental section.
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We also assume that the NADP radical dismutates to form
a (NADP)2 dimer (reaction (11)). Even though the rate
constant for this reaction is fairly high, the actual rate of
(NADP)2 formation is low because the concentration of the
radical is always very low. We have not included any
oxidation of the dimer to NADP1. Some enzymes such as
peroxidase are able to use (NADP)2 as a substrate (Kirkor
and Scheeline, 2000).
NADPH production is assumed to come exclusively from
the hexose monophosphate shunt (Henderson and Chappell,
1996). In the absence of any further knowledge about the
dynamics of this reaction pathway, we assume that NADPH
production is constant (reaction (12)). The entry of O2 from
the neighboring tissue into the cytoplasm of the neutrophil is
considered to be due to simple diffusion:
O2ðcytoplasmÞ: (13)
Here we have taken a very conservative view on the
maximum rate of oxygen diffusion into the cell (;0.75 mM
per minute), which is small compared to the rate of oxygen
consumption in cardiac tissue (McCord, 2000).
Reactions occurring in the phagosome
These include the classical peroxidase cycle:
H2O21per31 compound I (1)
compound I1MLTH ! compound II1MLT (2)
and
compound II1MLTH ! per311MLT: (3)
Note that reaction (1), in contrast to the corresponding
reaction involving horseradish peroxidase, is reversible
(Furtmu¨ller et al., 2000). The rate constants for reactions
(1), k1 and k1 listed in Table 1 are taken from Furtmu¨ller
et al. (2000), whereas the rate constants k2 and k3 are taken
from Allegra et al. (2001).
The free ferric enzyme may form compound III by
reaction with superoxide:
per311O2 ! compound III: (4)
In the absence of any reported rate constant for
TABLE 1 Reactions and rate constants of the model of neutrophilic production of reactive oxygen species
Reaction Rate expression (Ri) Rate constant
Reactions occurring in phagosome:
1. H2O21per31
k1
k1
coI k1½H2O2p½per31p  k1½coIp k1 ¼ 5:03 107 M1 s1
k1 ¼ 58 s1
2. coI1MLTH!k2 coII1MLT k2½coIp½MLTHp k2 ¼ 1:03 107 M1 s1
3. coII1 MLTH!k3 per311 MLT k3½coIIp½ MLTHp k3 ¼ 4:03 103 M1 s1
4. per311O2 !
k4
coIII k4½per31p½O2 p k4 ¼ 2:03 107 M1 s1
5. 2H112O2 !
k5 H2O21O2 k5½O2 2p k5 ¼ 1:03 107 M1 s1
6. coIII1O2 !
k6
coI1O2 k6½coIIIp½O2 p k6 ¼ 1:03 105 M1 s1
Reactions occurring in cytoplasm:
7. NADPH1O2!
k7 NADP11H2O2 k7½NADPHc½O2c k7 ¼ 1 M1 s1
8. NADP1O2!
k8 NADP11O2 k8½NADPc½O2c k8 ¼ 5:03 107 M1 s1
9. 2H112O2 !
k9 H2O21O2 k9½O2 2c k9 ¼ 5:03 108 M1 s1
10. MLT1NADPH!k10 MLTH1NADP k10½ MLTc½NADPHc k10 ¼ 1:03 107 M1 s1
11. 2NADP!k11 ðNADPÞ2 k11½NADP2c k11 ¼ 6:03 107 M1 s1
12. !k12 NADPH k12 k12 ¼ 22  35 mM s1
13. 
k13
k13
O2ðcytoplasmÞ k13  k13½O2c k13 ¼ 12:5 mM s1
k13 ¼ 4:53 102 s1
Diffusion terms:
14. O2ðphagosomeÞ
k14
k14
O2ðcytoplasmÞ k14ð½O2p  ½O2cÞ k14 ¼ 30 s1
15. H2O2ðphagosomeÞ
k15
k15
H2O2ðcytoplasmÞ k15ð½H2O2p  ½H2O2cÞ k15 ¼ 30 s1
16. MLTHðphagosomeÞk16
k16
MLTHðcytoplasmÞ k16ð½ MLTHp  ½ MLTHcÞ k16 ¼ 10 s1
17. MLTðphagosomeÞk17
k17
MLTðcytoplasmÞ k17ð½ MLTp  ½ MLTcÞ k17 ¼ 10 s1
18. O2 ðphagosomeÞ
k18
k18
O2 ðcytoplasmÞ k18ð½O2 p  ½O2 cÞ k18 ¼ < 0:01 s1
NADPH oxidase:
19. NADPHðcytoplasmÞ12O2ðphagosomeÞ
! NADP1ðcytoplasmÞ12O2 ðphagosomeÞ
Vað11aÞ
ðL1ð11aÞ2Þ
½O2p
KO1½O2p
; a ¼ ½NADPHc
KNADPH
V ¼ 288 mM s1
L ¼ 550
KO ¼ 1:5 mM
KNADPH ¼ 60 mM
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myeloperoxidase we have used the corresponding rate
constant k4 measured for horseradish peroxidase (Scheeline
et al., 1997). In homogeneous solution there is an alternative
way of forming compound III through reduction of ferric
peroxidase to ferrous peroxidase by the NAD(P) radical and
subsequent oxygenation of ferrous peroxidase (Bronnikova
et al., 1995). However, as the NAD radical is probably not
able to enter the phagosome, these reactions are not included
in the present model. As in the cytosol superoxide may
disproportionate (reaction (5)), but in this case the reaction is
not considered to be catalyzed by superoxide dismutase. In
most detailed models compound III is reduced to compound
I through reaction with the NAD(P) radical. For the same
reason as given above for the formation of ferrous peroxidase
this reaction is probably not occurring in the phagosome.
Instead we have included the reaction:
compound III1O2 ! compound I1O2 (6)
as recently proposed in Baker et al. (2000). In the absence of
detailed knowledge about the magnitude of k6, we have
chosen a reasonably low value for this reaction.
Diffusion terms
The present model assumes exchange of electrons between
components in two different cellular compartments. The
following species must be able to permeate the lipid mem-
brane, either by simple diffusion or by mediated transport:
oxygen and hydrogen peroxide, melatonin and its corre-
sponding free radical, and superoxide. The latter molecule
will probably cross the lipid membrane as the uncharged
protonated form (HO2). However, we cannot exclude that the
phagosome membrane, like the plasma membrane, contains
an anion channel through which the unprotonated form can
enter the phagosome. In any case the rate of diffusion of O2
across the phagosome membrane will be considered to be
very slow. The diffusional terms are computed from Fick’s
law of diffusion:
JX ¼ PXð½Xp  ½XcÞ; (6)
where JX is the ﬂux (mol/unit area) of substance X, and PX is
the permeability coefﬁcient of that substance. The perme-
ability coefﬁcients are converted to pseudo ﬁrst order rate
constants and the magnitude of these constants are calculated
from the equations:
kX ¼ 3PXr ; (6)
where r is the radius of the phagosome. Because r is of the
order of 0.2–0.5 mm, and the permeability coefﬁcients are of
the order of 107 cm/s to 103 cm/s, we can compute ﬁrst
order coefﬁcients for the reactions (14)–(18) of 0.006 s1 to
150 s1. The permeability coefﬁcient of H2O2 for the plasma
membrane of Chara corallina was estimated as 3.6 3 104
cm/s (Henzler and Steudle, 2000) suggesting a ﬁrst order
constant of 20–50 s1. We can easily assume that
the permeability coefﬁcient of O2 is no less than that. As
for the permeability coefﬁcients of melatonin and its free
radical form, we have assumed values around 104 cm/s
resulting in pseudo ﬁrst order constants of the order of 10 s1.
It was previously shown that melatonin can easily cross lipid
bilayers, suggesting a high permeability coefﬁcient (Costa
et al., 1995).
NADPH oxidase
Upon activation of neutrophils, this membrane-associated
multisubunit enzyme is recruited and assembled in the
phagosome membrane (Hampton et al., 1998; Henderson
and Chappell, 1996; Jones et al., 2000). The function of the
enzyme is to produce superoxide radicals in the phagosome.
The electrons needed for the reduction of oxygen come from
NADPH, which again is formed by the hexose mono-
phosphate shunt. The stoichiometry of the reaction is:
NADPH12O2 ! NADP112O2 : (6)
NADPH oxidase is a very complex enzyme, the activity of
which requires the involvement of at least two G-proteins
(Jones et al., 2000). These proteins act as molecular switches
that turn the enzyme’s activity on and off when they alternate
between binding GTP in the active form and GDP in
the inactive form. Thus the activity of NADPH oxidase
undoubtedly has a very complex kinetics with respect to its
two substrates, NADPH and O2. Here we have taken a
simple nonlinear dependence of the enzyme kinetics of
NADPH oxidase, namely that the enzyme shows coopera-
tiveness with respect to the binding of NADPH and simple
Michaelis-Menten behavior with respect to O2 (see Table 1).
The dissociation constant for the binding of NADPH is set to
60 mM (Henderson and Chappell, 1996), and the Michaelis
constant for oxygen is assumed to be around 1.5 mM. The
maximal rate of the oxidase was estimated at 288 mM/s in
accordance with values of around 10 nmol/106 cells per 10
min reported in Levy et al. (1994). However, it should be
emphasized that the exact kinetic expression for NADPH
oxidase and the constants assumed for the binding of its
substrates as well as its maximal turnover number are not
critical for the behavior of the model.
The differential equations corresponding to the model
presented in Table 1 are listed in Table 2. The concentration
changes in the phagosome are indicated with a subscript
p whereas the concentration changes in the cytosol are
indicated with a subscript c. The factor f refers to the
fractional volume of the phagosome over the cytosol volume
and is set to 1:10 in all simulations. However, both higher
and lower values of f yield oscillating solutions of the
equations in Table 2.
Simulation results
In the absence of NADPH oxidase activity, the simulations
of the differential equations in Table 2 yield only damped
Model of Neutrophil Oscillations 73
Biophysical Journal 84(1) 69–81
oscillations, very much like the experimental time series
shown in Fig. 1. Sustained oscillations can be obtained if the
permeability coefﬁcient for superoxide is increased to
unrealistic high values, corresponding to values of k18 >
1 s1. However, introducing NADPH oxidase activity into
the model results in sustained oscillations. An example is
shown in Fig. 2. Here we have assumed a total concentration
of myeloperoxidase in the phagosome of around 300 mM.
This is a lower boundary estimated from the reported value
of an average cell concentration of around 30 mM if the
enzyme was uniformly distributed in the cell (Sørensen and
Borregaard, 1999). The melatonin free radical also oscillates
with the same frequency as the oscillations shown in Fig. 2.
When a neutrophil is activated, the hexose monophos-
phate shunt starts to produce NADPH through oxidation of
glucose-6-phosphate to ribulose-5-phosphate:
glucose  6  phosphate12NADP1 !
ribulose  5  phosphate12NADPH1CO2:
The NADPH produced is mainly used for the reduction of
oxygen to reactive oxygen species, i.e., hydrogen peroxide,
superoxide, and hydroxyl radical. We have simulated the
ﬂux of production of NADPH as a single constant, k12, the
value of which is increasing as the neutrophils are activated.
Fig. 3 shows the effect on the oscillation period when k12 is
increased from 23.5 to 34 mM/s. Outside this interval the
system displays only steady-state behavior. We note that as
k12 is increased, the oscillation period decreases from around
200 s to between 15 and 20 s. These periods are in the same
range as those observed experimentally in migrating
neutrophils (Amit et al., 1999).
The oscillation period is less sensitive to concentrations of
peroxidase and melatonin. Fig. 4 shows the change in
oscillation period when the concentration of peroxidase is
increased from 200 mM to 800 mM and the concentration of
melatonin is increased from 200 mM to 1000 mM. At low
initial concentrations of the enzyme, an increase in the initial
concentration of melatonin is accompanied by a dramatic
increase in oscillation amplitude (Fig. 5).
As mentioned above, sustained oscillations in our model
system cannot be accomplished without some NADPH
oxidase activity. The amount of NADPH oxidase activity
in the model has very little effect on the oscillation amplitude
or the period. However, the higher the maximum NADPH
TABLE 2 Differential equations
Phagosome:
d½per31p=dt ¼ R11R3  R4
d½coIp=dt ¼ R1  R21R6
d½coIIp=dt ¼ R2  R3
d½coIIIp=dt ¼ R4  R6
d½H2O2p=dt ¼ R11R5  R15
d½O2 p=dt ¼ R4  2R5  R6  R1812R19
d½O2p=dt ¼ R51R6  R14  2R19
d½MLTHp=dt ¼ R2  R3  R16
d½MLTp=dt ¼ R21R3  R17
Cytoplasm:
d½NADPHc=dt ¼ R7  R101R12  R19
d½NADPc=dt ¼ R81R10  2R11
d½H2O2c=dt ¼ R71R91fR15
d½O2 c=dt ¼ R8  2R91fR18
d½O2c=dt ¼ R7  R81R91R131fR14
d½MLTHc=dt ¼ R101fR16
d½MLTc=dt ¼ R101fR17
FIGURE 2 Simulated time series of the concentrations of cytosolic
NADPH, oxygen, and NADP radical as well as superoxide and hydrogen
peroxide in the phagosome. The simulations were made using the model
listed in Table 1 and Table 2. The ﬂux of formation of NADPH (k12) was set
at 30 mM/s. Other parameters as listed in Table 1. The initial concentrations
of ferric peroxidase and melatonin were both 300 mM. The initial con-
centration of all other substances was zero.
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oxidase activity, the broader is the parameter regions where
sustained oscillations are observed. Thus, the formation of
superoxide through NADPH oxidation is not only crucial
in the release of superoxide in the phagosome. It is also
essential for the periodic formation of this radical. Our
simulations showed large periodic ﬂuctuations in the activity
of NADPH oxidase (Fig. 6). On the other hand, a system
consisting of NADPH oxidase alone, with the nonlinear
properties listed in Table 1, cannot give rise to oscillations.
Thus it is the cooperation of peroxidase and NADPH oxidase
that secures the periodic activity. Note that the amplitude
of the NADPH oxidase activity oscillations in Fig. 6 is
considerably smaller than the maximum velocity of that
enzyme V ¼ 288 mM s1 (Table 1). We were able to obtain
oscillations with considerably smaller values of V. This
implies that in order to abolish oscillatory dynamics in this
system, one would have to inhibit NADPH oxidase by more
than 75%.
Previously, it was postulated that the main function of
myeloperoxidase in the phagosome is to produce hypochlo-
rous acid from chloride according to the following reactions
(Furtmu¨ller et al., 2000):
H2O21per31  compound I; (1)
compoundII1Cl  compound I  Cl; (2 a)
and
compoundIICl ! per311HOCl: (2 b)
Obviously, the reactions 2 a and 2 b compete with
reactions 2 and 3 of our model. Furthermore, it was shown
(Hampton et al., 1998) that a substantial fraction of the H2O2
formed in the phagosome is converted into HOCl. In order to
check if these reactions have a profound impact on the
modeling results, we included them in the model and studied
the resulting simulations. Using the experimentally deter-
mined kinetic rate constants for reactions 2 a and 2 b
(Furtmu¨ller et al., 2000), we observed that including these
reactions in the model does indeed inhibit the oscillatory
behavior. However, with the kinetic parameters used, almost
100% of the oxygen taken up by the neutrophils would be
incorporated into HOCl. This does not match corresponding
experimental data showing that only 20–70 percent of H2O2
is incorporated. An explanation for this could be that the
parameters that were determined experimentally in vitro
might be different in the in vivo system. We therefore
reduced the rate constant for the forward reaction in Eq. 2 a
to such a degree that up to 70% of the oxygen consumed in
the phagosome is used for the production of HOCl. Under
these circumstances, the oscillatory behavior is restored (data
not shown) and the above described modeling results remain
valid.
Experiments with cells
We next sought to test certain assumptions of the model
described above and its predictions based upon the
FIGURE 3 Effect of the rate of NADPH inﬂux (k12) on the oscillation
period. Parameters and initial conditions as in Fig. 2.
FIGURE 4 Effect of the initial concentrations of (a) ferric peroxidase
(per31) and (b) melatonin on the oscillation period. The NADPH inﬂux rate
was 30 mM/s. In (a) the initial concentration of melatonin was 300 mM,
whereas in (b) the initial concentration of ferric peroxidase was 300 mM.
Other parameters and initial conditions as in Fig. 2.
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simulation results. The model replicates key features of an
activated neutrophil, such as the reliance on the hexose
monophosphate shunt (HMS), activation of the NADPH
oxidase, and mobilization of myeloperoxidase. In the ﬁrst
series of cell experiments, we sought to establish the
contribution of the HMS in NAD(P)H oscillations. To
accomplish this goal, we employed the reagent 6-amino-
nicotinamide (6-AN), which is known to block the activity of
glucose-6-phosphate dehydrogenase and 6-phosphogluco-
nate dehydrogenase; both of these enzymes are speciﬁc for
the HMS (White et al., 1978).
Adherent neutrophils were incubated in the presence or
absence of 6-AN at 10 mM for 30 min at 378C; previous
studies have shown that these conditions effectively block
neutrophil activation and the respiratory burst (e.g., Bender
and Van Epps, 1985). In the absence of added reagents,
NAD(P)H oscillations with a period of 20 s are observed.
However, the activating chemotactic peptide N-formyl-
methionyl-leucyl-phenylalanine (FMLP, 100 nM), which
induces a vigorous respiratory burst, triggers the appearance
of a 10 s period in NAD(P)H oscillations (Fig. 7), which has
been previously observed (Petty, 2001; Amit et al., 1999).
The reagent 6-AN has no effect on the 20 s oscillations, but
eliminates the acquisition of the 10 s NAD(P)H oscillation in
the presence of FMLP (Fig. 7). Parallel results were obtained
using the somewhat less speciﬁc reagent dexamethasone
(Fig. 7), which also inhibits glucose-6-phosphate dehydro-
genase (Whitcomb and Schwartz, 1985; Rom and Harkin,
1991; Mohan and Jacobson, 1993). As previously suggested
using various neutrophil activating substances (Petty, 2001;
Amit et al., 1999), these ﬁndings indicate that the 20 s
oscillation is associated with cell adherence/motility, but
not activation or utilization of the HMS, whereas the 10 s
oscillation is only found in activated cells and draws upon
the HMS.
One of the key ﬁndings in the simulation studies was that
the NADPH oxidase and myeloperoxidase cooperate in the
development of stable oscillations. To test this prediction, we
employed the reagent diphenyleneiodonium (DPI), which
inhibits the NADPH oxidase (Cross and Jones, 1986). Cells
were incubated with DPI at various concentrations for 45
min at 378C. In the range of 0–20 mg/ml DPI had no effect on
NAD(P)H oscillations (Fig. 8 A). At a higher dose of 25–35
mg/ml DPI, FMLP had no effect on NAD(P)H oscillations of
neutrophils (Fig. 8 B). No NAD(P)H oscillations were
observed at doses above 40 mg/ml DPI (Fig. 8 C). Under the
FIGURE 5 Effect of the concentration of mela-
tonin on the oscillation amplitude. Time series of
[NADPH] in the presence of an initial concen-
tration of melatonin of (a) 300 mM and (b) 350 mM.
(c) Envelope of the oscillations of NADPH plotted
against the concentration of melatonin ([MLTH])
in the cytoplasm. The NADPH inﬂux rate was 30
mM/s and the initial concentration of ferric
peroxidase was 200 mM. Other conditions as in
Fig. 2.
FIGURE 6 Simulated changes of activity of NADPH oxidase (reaction
(19) in Table 1). The ﬂux of formation of NADPH (k12) was set at 30 mM/s.
Other parameters as in Table 1. The initial concentrations of ferric per-
oxidase and melatonin were both 300 mM. The initial concentration of all
other substances was zero.
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conditions we have employed (adherent cells, HBSS, etc.),
concentrations in the range of 100 mg/ml appeared to be
toxic to the cells. Our ﬁndings conﬁrm the role of the
NADPH oxidase in establishing the 10 s NAD(P)H osci-
llation period.
Our modeling studies led to the unanticipated prediction
that melatonin should affect the amplitude of metabolic
oscillations in activated neutrophils. We therefore studied the
nature of melatonin interactions with adherent neutrophils
and its effect on NAD(P)H oscillations. In the ﬁrst series
of experiments, we examined melatonin-neutrophil inter-
actions. Previous studies have established that optimal
enhancement of the respiratory burst occurs at roughly 50–
100 mM melatonin (Recchioni et al., 1998). Therefore,
neutrophils were incubated with 50 mM melatonin for 30
min at 378C followed by addition of 50 nM FMLP. The
oxidation of melatonin by peroxidase is accompanied by
chemiluminescence via a dioxetane intermediate (Silva et al.,
2000). The chemiluminescence properties of melatonin in
neutrophils were examined using an imaging spectropho-
tometer system. The chemiluminescence spectrum was
centered at ;515 nm (Fig. 9 C). Using an intensiﬁer and
camera cooled to 208C, the chemiluminescence was
imaged by accumulating data for 10 s. These images showed
that FMLP-treated cells exhibited chemiluminescence within
the anterior region of the cell body and lamellipodium (Fig. 9
B), which are areas rich in intracellular granules and
peroxidase. When the chemiluminescence was quantitated
as a function of time, it was found to oscillate (Fig. 9 D), as
does hydrogen peroxide, a cofactor in its oxidation. There-
fore, melatonin undergoes chemical reactions within living
human neutrophils.
We next tested the effect of melatonin on NAD(P)H
oscillations of neutrophils. Incubation of neutrophils with
melatonin (50 mM) for 30 min at 378C had no effect on
nonactivated neutrophils expressing the 20 s NAD(P)H
oscillations (Fig. 10 A). In contrast, FMLP-activated
neutrophils displayed enhanced NAD(P)H oscillatory am-
plitudes in the presence of melatonin (Fig. 10, A and D).
Thus, the melatonin effect anticipated by the model (Fig. 5)
is replicated in living cells (Fig. 10), but only during
neutrophil activation, which, in turn, is an explicit condition
of the model. In the absence of cell stimulation, 20 s
oscillations and low levels of reactive oxygen metabolite
(ROM) production are found for polarized cells (Fig. 10 B),
as previously described (Petty, 2001; Amit et al., 1999). The
level of ROM production is enhanced by activating agents
such as FMLP and further enhanced by the inclusion of
melatonin (Fig. 10, B, C, E, and F). This accounts for the
‘‘priming’’ effect of melatonin reported in the literature
(Recchioni et al., 1998, Morrey et al., 1994); melatonin is
incapable of initiating a respiratory burst, but is capable of
enhancing ROM production in the presence of a second
activating signal.
DISCUSSION
In the present study we have developed a robust in silico
model of cell metabolism during neutrophil activation and
tested several experimentally accessible features of the
model on living neutrophils. The model encompasses several
essential cellular and chemical features of activated neu-
trophils. Key features include the activation of the NADPH
oxidase, delivery of myeloperoxidase to endosomes, and
activation of the HMS. The model is robust in the sense that
it is consistent with previous experimental ﬁndings and
successfully predicted the behavior of neutrophil metabolism
in the presence of melatonin. The synergy between the in
silico and in vitro methods in cell biology has enhanced
greatly our understanding of the links between the dynamics
of intracellular chemistry and time-varying properties of
neutrophil physiology.
Previous experimental studies have shown that polarized
FIGURE 7 The effects of 6-aminonicotinamide and dexamethasone on
NAD(P)H oscillations of polarized neutrophils. When neutrophils are
exposed to 100 nM FMLP, the frequency of the NAD(P)H oscillations are
approximately doubled. 6-aminonicotinamide, a regent that speciﬁcally
blocks the HMS, has no effect on untreated cells, but blocks the frequency
change accompanying FMLP exposure. A similar effect was noted with the
inhibitory drug dexamethasone.
FIGURE 8 The effect of DPI on NAD(P)H
oscillations (a, c, and e) and superoxide release,
as judged by the conversion of hydroethidine to
ethidium bromide in the cellular environment, for
polarized neutrophils. Although DPI had no effect
on FMLP-stimulated NAD(P)H oscillations at low
doses (0–10 mg/ml), doses in the range of 20–50
mg/ml DPI blocked acquisition of the;10 s period
oscillation. Higher doses caused metabolic dynam-
ics to disappear. Superoxide release paralleled the
changes in NAD(P)H oscillations.
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neutrophils exhibit NAD(P)H oscillations with a period of
;20 s for untreated cells and;10 s for activated neutrophils
(Petty, 2001; Amit et al., 1999). These two distinct periods
apparently correspond to two different biochemical path-
ways. The 20 s oscillatory period presumably reﬂects the
glycolytic apparatus (the nonHMS, 6-AN-insensitive com-
ponent (Fig. 7)) whereas the 10 s oscillation corresponds to
the HMS/NADPH oxidase/myeloperoxidase-dependent (6-
AN-sensitive) component of metabolism for activated
neutrophils, as modeled above.
The model predicts metabolic oscillations whose period is
consistent with experimental observations. The central
feature of the model is the cooperation of the NADPH
oxidase and myeloperoxidase. The requirement of the
NADPH oxidase to stabilize the oscillatory pattern has been
conﬁrmed by inactivating the oxidase using DPI, an inhibitor
of the oxidase (Cross and Jones, 1986). As predicted by the
modeling results, higher concentrations of DPI blocked the
10 s oscillations. Interestingly, at a DPI dose of 25–35 mg/
ml, the 20 s oscillation was observed in the presence of
FMLP. We suggest that this concentration range is
associated with inhibition of the stable oscillations linked
with NADPH oxidase-myeloperoxidase cooperation, but
that the glycolytic pathway is not signiﬁcantly affected. At
higher DPI concentrations, additional metabolic pathways
might be affected.
The model predicted that melatonin enhances the ampli-
tude of NAD(P)H oscillations. The melatonin effect was
subsequently tested in neutrophils. Our results showed that
melatonin, indeed, enhanced the amplitude of the 10 s
NAD(P)H oscillations of activated neutrophils, but had no
effect on the 20 s NAD(P)H oscillations. Not only does this
conﬁrm the model described above, but it is also consistent
with the association of the 10 and 20 s NAD(P)H oscillations
with two distinct metabolic pathways. Thus, the model has
successfully accounted for prior experimental observations
and predicted the effects of DPI and melatonin on living cells.
Oscillations in NAD(P)H are accompanied by oscillations
FIGURE 9 Chemiluminescence properties of melatonin-labeled neutrophils. The chemiluminescence was imaged using a cooled detector. DIC and
chemiluminescence images are shown in panels a and b, respectively. The chemiluminescence spectrum is shown in panel c. In panel d the chemiluminescence
intensity is plotted as a function of time, which shows oscillations in the output intensity.
FIGURE 10 The effects of melatonin (50 mM)
and FMLP (50 nM) on NAD(P)H oscillations and
oxidant release. (A) Although melatonin alone has
no effect on NAD(P)H oscillations, when FMLP is
added to the cells both the frequency and amplitude
of the oscillations are increased. (B and C) The
production of oxidants as detected by tetramethylr-
hosamine and EB formation are dramatically
enhanced in the presence of melatonin and FMLP.
(D) As noted in Fig. 7, FMLP increases the
frequency of NAD(P)H oscillations. When mela-
tonin is added, the amplitude increases. (E and F)
The production of oxidants is enhanced by FMLP
and further enhanced when melatonin is added.
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in superoxide and hydrogen peroxide production (Fig. 2).
Changes in NAD(P)H oscillation frequency or amplitude are
paralleled by changes in oxidant production. The low levels
of oxidant production shown above for nonactivated
neutrophils displaying the 20 s oscillation have been
previously observed by several laboratories (Demaurex et
al., 1996; Ginis and Tauber, 1990; Kindzelskii et al., 1998).
These oscillations are apparently independent of the HMS.
Activation of the HMS is accompanied by higher frequency
oscillations and enhanced oxidant production.
The modeling studies described above characterize the
properties of activated neutrophils; hence, they do not
address the 20 s NAD(P)H oscillations. Also, the modeling
results do not account for the dominance of the 10 s
oscillations in the presence of neutrophil activating stimuli.
We believe that the disappearance of the 20 s component
may be due to a greater ﬂux of carbon through the HMS
relative to glycolysis. Further analysis of the glycolytic
pathway in neutrophils should provide further insights into
the coupling of these two oscillators. Importantly, combined
modeling/experimental studies should help explain cell-
mediated damage due to high glucose levels in diabetes and
the unusual metabolic changes in neutrophils during
polytrauma (Oehler et al., 2000).
The effect of melatonin on activated leukocytes is
interesting for several reasons. Melatonin is a pineal
hormone and a biosynthetic product of leukocytes (Finoc-
chiaro et al., 1991). It has an unexplained ability to prime
neutrophils and monocytes for oxidant production, cytotox-
icity, and other functions (Recchioni et al., 1998; Morrey et
al., 1994). Melatonin, a priming agent, enhances oxidant
production in response to activating stimuli, such as
lipopolysaccharide and phorbol myristate acetate (PMA),
but does not induce a response in the absence of an activating
stimulus. Previous studies have demonstrated the priming of
oxidant production using ﬂow cytometric and superoxide
dismutase-inhibitable cytochrome c reduction methodolo-
gies (Recchioni et al., 1998; Morrey et al., 1994). In the
present study we conﬁrm these ﬁndings using single cell
ﬂuorescence techniques and correlate this enhancement with
an increase in the amplitude of NAD(P)H oscillations. Other
studies have shown that activated neutrophils oxidize
melatonin (Silva et al., 2000; Recchioni et al., 1998), which
suggests that chemical reactions of melatonin participate in
leukocyte priming.
The modeling studies also suggest a likely chemical
mechanism of melatonin-induced neutrophil priming. The
enhanced NADPH and oxidant oscillatory amplitudes
predicted by the model and observed experimentally explain
why the levels of oxidant production are higher in the
presence of melatonin. Because the model is only applicable
to activated neutrophils, nonactivated neutrophils are not
susceptible to melatonin-mediated enhancement. This is
mainly due to the fact that the model predicts that melatonin
enhances the myeloperoxidase catalyzed oxidation of
NAD(P)H. Myeloperoxidase is only released from granules
upon activation of the neutrophils. Therefore, as a priming
agent, it cannot enhance oxidant production in the absence of
an activating stimulus.
The ability of melatonin to enhance oxidant production by
leukocytes may seem paradoxical due to its ability to
scavenge reactive oxygen and nitrogen species (Matuszak
et al., 1997; Zhang et al., 1998). In a physiological context,
however, these contrasting abilities may be advantageous.
In the local environment of a neutrophil, melatonin would
promote higher oxidant levels, thereby enhancing host
defense. However, at some distance from a neutrophil,
melatonin’s ability to act as a scavenger may minimize
collateral damage to healthy host tissues.
Enhanced amplitudes of NAD(P)H and superoxide
oscillations have also been observed in neutrophils in
response to the biological factors interferon-g (Adachi
et al., 1999; Rosenspire et al., 2000) and interleukin-12
(unpublished) and other stimulatory conditions provided by
PMA and electric ﬁelds (Kindzelskii and Petty, 2000). Not
surprisingly, at appropriate doses interferon-g and PMA
prime cells for oxidant production (Tyagi et al., 1988; Berton
et al., 1986). Interferon-g and interleukin-12 transmit
intracellular signals via calcium (Aas et al., 1998; Aas et
al., 1999; Collison et al., 1998). Furthermore, PMA acts on
the calcium signaling circuitry (Tauber, 1987). Thus, similar
metabolic responses can be achieved by several calcium-
related stimuli. One possibility to account for this is that
calcium signals may promote mixing of the NADPH oxidase
and myeloperoxidase into the same compartment via
membrane fusion whereas melatonin may promote electron
trafﬁcking in the absence of vesicle fusion. Alternatively,
because interferon-g induces the synthesis of melatonin
(Finocchiaro et al., 1988), it is possible that melatonin is the
mediator responsible for the interferon-g-mediated enhance-
ment of NAD(P)H and oxidant oscillations. Because
melatonin is relatively mobile, one might discriminate
between these two possibilities by mixing interferon-g-
primed cells with untreated cells then assaying for amplitude
modulation in the untreated cells.
One problem with the conventional reductionist approach
to rational drug development is that a speciﬁc compound
designed to affect a speciﬁc enzyme often has just the
opposite of the desired effect at the cellular level or in patient
care. A goal of biocomplexity research is the identiﬁcation of
important interactions, pathways, feedback loops, etc. such
that biochemical pathways and living tissues can be
intelligently perturbed. Due to their relative simplicity and
profound clinical importance, neutrophils are an excellent
system for computational analysis. Our model of neutrophil
activation was found to be consistent with earlier exper-
imental ﬁndings and successfully predicted the novel
experimental results described above (Figs. 7–10). The
apparent resolution of the mechanism of melatonin-mediated
neutrophil priming is a useful example of the importance of
Model of Neutrophil Oscillations 79
Biophysical Journal 84(1) 69–81
computer simulations in biology. The interplay of in silico
and in vitro research will have a major impact on modern
biology and medicine.
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